APPLICATION
NDA050092
TYPE
NDA
ORIGINAL APPROVAL
1968-04-22
LATEST ACTION
1991-04-10
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
PATHOCILDiscontinued
DICLOXACILLIN SODIUM EQ 62.5MG BASE/5ML · FOR SUSPENSION · ORAL
Approval history
1991-04-10Labeling · Supplement 4AP
1986-01-09Manufacturing (CMC) · Supplement 3AP
1985-08-12Labeling · Supplement 2AP
1984-09-05Manufacturing (CMC) · Supplement 1AP
1980-10-22Labeling · Supplement 32AP
1980-08-26Labeling · Supplement 31AP
1976-11-02Manufacturing (CMC) · Supplement 30AP
1976-10-15Manufacturing (CMC) · Supplement 29AP
1976-09-23Labeling · Supplement 28AP
1976-03-25Labeling · Supplement 27AP
1975-08-15Labeling · Supplement 26AP
1975-05-30Labeling · Supplement 25AP
1974-04-18Labeling · Supplement 24AP
1974-04-11Manufacturing (CMC) · Supplement 23AP
1974-04-01Labeling · Supplement 22AP
1974-01-14Manufacturing (CMC) · Supplement 21AP
1973-11-27Labeling · Supplement 20AP
1973-11-14Manufacturing (CMC) · Supplement 19AP
1971-07-29Manufacturing (CMC) · Supplement 18AP
1971-04-14Labeling · Supplement 17AP
1970-08-11Manufacturing (CMC) · Supplement 15AP
1969-11-26Labeling · Supplement 14AP
1969-11-26Manufacturing (CMC) · Supplement 13AP
1969-11-13Labeling · Supplement 12AP
1969-06-03Labeling · Supplement 11AP
1969-05-27Labeling · Supplement 10AP
1968-12-20Labeling · Supplement 8AP
1968-11-19Labeling · Supplement 7AP
1968-07-12Manufacturing (CMC) · Supplement 5AP
1968-04-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.